Research explores how wind-power producers can survive and improve profits despite market uncertainty, price volatility and ...
How-To Geek on MSN
Outlook is hiding a powerful automation tool—here's how to use it
The best tool you're probably not using.
Q4 FY2025 earnings call: 2026 revenue and margin guidance, ReposiTrak partnership, and key risks after divestitures.
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of ...
Imcivree’s approval in a type of obesity driven by brain injury could unlock an opportunity Wall Street analysts believe to ...
Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to report results from updated technical reports for its Greenstone Gold Mine (“Greenstone”) located in ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...
Metatek begins trading on TSX after IPO, as strong demand for energy and mineral exploration drives backlog and expansion ...
Conference Call/Webcast Today at 5:00 pm ET TORONTO and DALLAS, March 31, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" ...
Similar to Kyle Pitts, the fantasy industry is looking for former first-round pick Evan Engram to become relevant again in 2025. Engram signed a 2-year contract with the Denver Broncos in March. The ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results